Efficacy Study of Phytotherapy "Raylis" In Congestive Processes Of The Pelvic Organs (Prostatostasis)

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to investigate the efficacy of Phytotherapy "Raylis" (Ginseng Root Powder 50 mg, False Ginseng Root Powder 50 mg, Codonopsis Root Powder 50 mg, Astragalus Membranaceus Root Powder 50 mg, Epimedium Alpinum Herbal Extract 100 mg) In Congestive Processes Of The Pelvic Organs (Prostatostasis) In Congestive Processes Of The Pelvic Organs (Prostatostasis)

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Clinic of Men's Health and Couple Longevity, Russia

Criteria

Inclusion Criteria:

• Age 20-60 years

• Symptoms of prostatostasis lasting for at least 3 months during the past 6 months:

• Pathological changes on uroflowmetry (maximum flow rate of less than 15 ml / s, average urinary flow rate of less than 12 ml / sec)

• TRUS Prostate volume more than 22 ml at TRUS

• TRUS picture of Prostatostasis

• I-PSS 7-20

• IIEF-5) - 12-21

Exclusion Criteria:

• Contraindications and limitations to use of the drug Raylis listed in the instructions for medical use *

• Diabetes mellitus (type 1 and type 2, decompensation)

• Neurogenic disorders (acute cerebral circulatory disorders, Alzheimer's disease, spinal cord injury)

• A history of pelvic trauma

• Patients who had undergone radical prostatectomy and other surgical interventions on the pelvic organs

• Concomitant use of supplements to improve the erectile function, use of the anti-androgens, anti-depressants, finasteride.

• Diagnosed BPH

• Current participation in a clinical trial and / or study medication for 30 days prior to inclusion

• Any form of substance abuse, mental disorder or condition which, in the opinion of the investigator, may complicate communication with the researcher.

• The inability or unwillingness to comply with the scheme of visits according to protocol.